title: Zidovudine and reduction of vertical transmission of HIV in Africa. ANRS 049 Trial Group.
authors.forename: P
authors.initials: P
authors.lastname: Msellati
authors.forename: N
authors.initials: N
authors.lastname: Meda
authors.forename: C
authors.initials: C
authors.lastname: Welffens-Ekra
authors.forename: V
authors.initials: V
authors.lastname: Leroy
authors.forename: P
authors.initials: P
authors.lastname: Van de Perre
authors.forename: L
authors.initials: L
authors.lastname: Mandelbrot
authors.forename: F
authors.initials: F
authors.lastname: Dabis
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001942:Breast Feeding / Q000009:adverse effects*; D002050:Burkina Faso; D007560:Cote d'Ivoire; D003376:Counseling / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D013997:Time Factors; D015215:Zidovudine / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D015215:Zidovudine